Dariohealth CORP DEF 14A proxy statements

DarioHealth Corp. calls its Annual Meeting for January 29, 2026, to vote on director re-elections, auditor ratification, prior equity issuances, an expanded incentive plan, executive compensation, and a charter amendment.

DarioHealth Corp. is calling its annual meeting to vote on critical proposals including a reverse stock split to maintain Nasdaq listing, a significant increase in authorized shares for future capital needs, and amendments to its equity compensation plan.

DarioHealth Corp. is seeking stockholder approval for the conversion of preferred stock, issuance of common stock, and amendments to warrants and loan agreements with Avenue Venture Opportunities Fund.

DarioHealth Corp. will hold its annual stockholders meeting on December 18, 2024, to vote on the re-election of directors and the ratification of its independent auditor.

DarioHealth Corp. is holding a special meeting of stockholders on June 25, 2024, to vote on proposals related to share issuance following the acquisition of Twill Inc. and an amendment to the company's equity incentive plan.